Humana Inc Stock Current Ratio
HUM Stock | USD 346.72 2.78 0.80% |
Humana Inc fundamentals help investors to digest information that contributes to Humana's financial success or failures. It also enables traders to predict the movement of Humana Stock. The fundamental analysis module provides a way to measure Humana's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Humana stock.
As of the 29th of March 2024, Current Ratio is likely to grow to 2.01. Humana | Current Ratio |
Humana Current Ratio Analysis
Humana's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
More About Current Ratio | All Equity Analysis
Humana Current Ratio |
|
Current Ratio | = | Current AssetCurrent Liabilities |
Current Humana Current Ratio | 1.53 X |
Most of Humana's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humana Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Humana Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Humana is extremely important. It helps to project a fair market value of Humana Stock properly, considering its historical fundamentals such as Current Ratio. Since Humana's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Humana's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Humana's interrelated accounts and indicators.
Click cells to compare fundamentals
Humana Current Ratio Historical Pattern
Today, most investors in Humana Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Humana's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Humana current ratio as a starting point in their analysis.
Humana Current Ratio |
Timeline |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition |
Humana Short Term Coverage Ratios
Short Term Coverage Ratios |
|
In accordance with the recently published financial statements, Humana Inc has a Current Ratio of 1.53 times. This is 47.42% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current ratio for all United States stocks is 29.17% higher than that of the company.
Humana Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Humana's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Humana could also be used in its relative valuation, which is a method of valuing Humana by comparing valuation metrics of similar companies.Humana is currently under evaluation in current ratio category among related companies.
Humana ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Humana's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Humana's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Humana Fundamentals
Return On Equity | 0.16 | ||||
Return On Asset | 0.0634 | ||||
Profit Margin | 0.02 % | ||||
Operating Margin | 0 % | ||||
Current Valuation | 49.45 B | ||||
Shares Outstanding | 120.55 M | ||||
Shares Owned By Insiders | 0.20 % | ||||
Shares Owned By Institutions | 94.13 % | ||||
Number Of Shares Shorted | 2.24 M | ||||
Price To Earning | 19.12 X | ||||
Price To Book | 2.59 X | ||||
Price To Sales | 0.40 X | ||||
Revenue | 106.44 B | ||||
Gross Profit | 17.18 B | ||||
EBITDA | 4.6 B | ||||
Net Income | 2.49 B | ||||
Cash And Equivalents | 5.06 B | ||||
Cash Per Share | 143.73 X | ||||
Total Debt | 12.27 B | ||||
Debt To Equity | 0.85 % | ||||
Current Ratio | 1.53 X | ||||
Book Value Per Share | 133.05 X | ||||
Cash Flow From Operations | 3.98 B | ||||
Short Ratio | 1.26 X | ||||
Earnings Per Share | 19.99 X | ||||
Price To Earnings To Growth | 1.45 X | ||||
Target Price | 408.44 | ||||
Number Of Employees | 67.6 K | ||||
Beta | 0.45 | ||||
Market Capitalization | 42.13 B | ||||
Total Asset | 46.89 B | ||||
Retained Earnings | 27.54 B | ||||
Working Capital | 366.27 M | ||||
Current Asset | 2.76 B | ||||
Current Liabilities | 2.39 B | ||||
Z Score | 5.48 | ||||
Annual Yield | 0.01 % | ||||
Five Year Return | 0.64 % | ||||
Net Asset | 46.89 B | ||||
Last Dividend Paid | 3.54 |
About Humana Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Humana Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humana using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humana Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for 2024 | ||
Current Ratio | 1.59 | 2.01 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Humana Piotroski F Score and Humana Altman Z Score analysis. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Humana Stock analysis
When running Humana's price analysis, check to measure Humana's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humana is operating at the current time. Most of Humana's value examination focuses on studying past and present price action to predict the probability of Humana's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humana's price. Additionally, you may evaluate how the addition of Humana to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Humana's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Humana. If investors know Humana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Humana listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.28) | Dividend Share 3.54 | Earnings Share 19.99 | Revenue Per Share 858.783 | Quarterly Revenue Growth 0.179 |
The market value of Humana Inc is measured differently than its book value, which is the value of Humana that is recorded on the company's balance sheet. Investors also form their own opinion of Humana's value that differs from its market value or its book value, called intrinsic value, which is Humana's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Humana's market value can be influenced by many factors that don't directly affect Humana's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Humana's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humana is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humana's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.